Development
Cognex Corporation
CGNX
$41.36
$0.471.15%
NASDAQ
12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -17.86% | -5.91% | -11.69% | -28.78% | -1.90% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -17.86% | -5.91% | -11.69% | -28.78% | -1.90% |
Cost of Revenue | -11.80% | -5.08% | -19.60% | -27.17% | 1.14% |
Gross Profit | -20.36% | -6.22% | -8.55% | -29.41% | -3.10% |
SG&A Expenses | 18.99% | 9.20% | 4.34% | 2.72% | -8.46% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.04% | 1.59% | -6.38% | -8.54% | -2.45% |
Operating Income | -82.33% | -35.02% | -24.07% | -74.45% | -0.07% |
Income Before Tax | -75.77% | -31.37% | 5.22% | -70.11% | 2.22% |
Income Tax Expenses | -20.28% | 50.72% | 86.85% | -97.05% | -11.15% |
Earnings from Continuing Operations | -79.70% | -44.33% | -2.42% | -61.96% | 3.32% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -79.70% | -44.33% | -2.42% | -61.96% | 3.32% |
EBIT | -82.33% | -35.02% | -24.07% | -74.45% | -0.07% |
EBITDA | -72.54% | -30.92% | -22.61% | -70.45% | 0.11% |
EPS Basic | -79.58% | -43.96% | -1.83% | -61.61% | 5.36% |
Normalized Basic EPS | -81.00% | -42.26% | -19.71% | -69.85% | 8.03% |
EPS Diluted | -81.43% | -42.16% | -2.80% | -60.95% | 6.78% |
Normalized Diluted EPS | -80.96% | -42.27% | -19.58% | -69.64% | 9.21% |
Average Basic Shares Outstanding | -0.53% | -0.63% | -0.62% | -0.87% | -1.95% |
Average Diluted Shares Outstanding | -0.77% | -0.56% | -0.78% | -1.57% | -3.02% |
Dividend Per Share | 7.14% | 7.69% | 7.69% | 7.69% | 7.69% |
Payout Ratio | 4.25% | 0.92% | 0.10% | 1.81% | 0.02% |